(DOCU) DocuSign - Ratings and Ratios
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US2561631068
E-Signature, CLM, IAM, Notary, Identify
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 44.6% |
| Value at Risk 5%th | 67.3% |
| Relative Tail Risk | -8.29% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.25 |
| Alpha | -36.53 |
| CAGR/Max DD | 0.24 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.510 |
| Beta | 1.301 |
| Beta Downside | 1.414 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.20% |
| Mean DD | 20.40% |
| Median DD | 20.62% |
Description: DOCU DocuSign October 30, 2025
DocuSign, Inc. (NASDAQ:DOCU) offers a cloud-based Intelligent Agreement Management (IAM) platform that combines electronic signatures, Contract Lifecycle Management (CLM), document generation, and niche solutions such as remote notarization, signer-identification, and real-estate transaction workflows, all compliant with FedRAMP and industry-specific regulations.
In FY 2023 the company generated roughly $2.1 billion in revenue-a ~20% YoY increase-and reported an annual recurring revenue (ARR) run-rate exceeding $2.3 billion with gross margins above 80%. Growth is being propelled by macro trends like sustained remote-work adoption, heightened demand for secure digital transaction infrastructure, and regulatory pushes for electronic record-keeping, while competition from Adobe Sign and emerging AI-driven contract tools intensifies market pressure.
For a deeper, data-rich assessment of DocuSign’s valuation dynamics, you may find the analytics on ValueRay worth a look.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (281.0m TTM) > 0 and > 6% of Revenue (6% = 185.7m TTM) |
| FCFTA 0.24 (>2.0%) and ΔFCFTA -0.79pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -14.78% (prev -9.23%; Δ -5.54pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.26 (>3.0%) and CFO 1.04b > Net Income 281.0m (YES >=105%, WARN >=100%) |
| Net Debt (-473.0m) to EBITDA (476.1m) ratio: -0.99 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.74 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (211.9m) change vs 12m ago 1.73% (target <= -2.0% for YES) |
| Gross Margin 79.34% (prev 79.17%; Δ 0.17pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 80.36% (prev 76.15%; Δ 4.21pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 134.6 (EBITDA TTM 476.1m / Interest Expense TTM 2.17m) >= 6 (WARN >= 3) |
Altman Z'' -2.35
| (A) -0.12 = (Total Current Assets 1.32b - Total Current Liabilities 1.78b) / Total Assets 3.95b |
| (B) -0.39 = Retained Earnings (Balance) -1.54b / Total Assets 3.95b |
| (C) 0.08 = EBIT TTM 291.9m / Avg Total Assets 3.85b |
| (D) -0.79 = Book Value of Equity -1.55b / Total Liabilities 1.96b |
| Total Rating: -2.35 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 78.83
| 1. Piotroski 6.50pt |
| 2. FCF Yield 6.90% |
| 3. FCF Margin 30.23% |
| 4. Debt/Equity 0.06 |
| 5. Debt/Ebitda -0.99 |
| 6. ROIC - WACC (= 1.31)% |
| 7. RoE 14.06% |
| 8. Rev. Trend 98.00% |
| 9. EPS Trend 24.48% |
What is the price of DOCU shares?
As of December 07, 2025, the stock is trading at USD 65.67 with a total of 8,928,752 shares traded.
Over the past week, the price has changed by -5.31%, over one month by -7.38%, over three months by -17.77% and over the past year by -21.52%.
Over the past week, the price has changed by -5.31%, over one month by -7.38%, over three months by -17.77% and over the past year by -21.52%.
Is DOCU a buy, sell or hold?
DocuSign has received a consensus analysts rating of 3.30.
Therefor, it is recommend to hold DOCU.
- Strong Buy: 3
- Buy: 3
- Hold: 16
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the DOCU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 92.8 | 41.3% |
| Analysts Target Price | 92.8 | 41.3% |
| ValueRay Target Price | 61.1 | -6.9% |
DOCU Fundamental Data Overview December 05, 2025
Market Cap USD = 14.27b (14.27b USD * 1.0 USD.USD)
P/E Trailing = 51.9265
P/E Forward = 16.8634
P/S = 4.61
P/B = 6.9123
P/EG = 0.4099
Beta = 0.983
Revenue TTM = 3.10b USD
EBIT TTM = 291.9m USD
EBITDA TTM = 476.1m USD
Long Term Debt = 126.9m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 21.2m USD (from shortTermDebt, last quarter)
Debt = 126.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -473.0m USD (from netDebt column, last quarter)
Enterprise Value = 13.55b USD (14.27b + Debt 126.9m - CCE 844.5m)
Interest Coverage Ratio = 134.6 (Ebit TTM 291.9m / Interest Expense TTM 2.17m)
FCF Yield = 6.90% (FCF TTM 935.7m / Enterprise Value 13.55b)
FCF Margin = 30.23% (FCF TTM 935.7m / Revenue TTM 3.10b)
Net Margin = 9.08% (Net Income TTM 281.0m / Revenue TTM 3.10b)
Gross Margin = 79.34% ((Revenue TTM 3.10b - Cost of Revenue TTM 639.5m) / Revenue TTM)
Gross Margin QoQ = 79.33% (prev 79.41%)
Tobins Q-Ratio = 3.43 (Enterprise Value 13.55b / Total Assets 3.95b)
Interest Expense / Debt = 0.65% (Interest Expense 828.0k / Debt 126.9m)
Taxrate = 17.64% (13.5m / 76.5m)
NOPAT = 240.4m (EBIT 291.9m * (1 - 17.64%))
Current Ratio = 0.74 (Total Current Assets 1.32b / Total Current Liabilities 1.78b)
Debt / Equity = 0.06 (Debt 126.9m / totalStockholderEquity, last quarter 1.99b)
Debt / EBITDA = -0.99 (Net Debt -473.0m / EBITDA 476.1m)
Debt / FCF = -0.51 (Net Debt -473.0m / FCF TTM 935.7m)
Total Stockholder Equity = 2.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.11% (Net Income 281.0m / Total Assets 3.95b)
RoE = 14.06% (Net Income TTM 281.0m / Total Stockholder Equity 2.00b)
RoCE = 13.73% (EBIT 291.9m / Capital Employed (Equity 2.00b + L.T.Debt 126.9m))
RoIC = 12.03% (NOPAT 240.4m / Invested Capital 2.00b)
WACC = 10.72% (E(14.27b)/V(14.40b) * Re(10.81%) + D(126.9m)/V(14.40b) * Rd(0.65%) * (1-Tc(0.18)))
Discount Rate = 10.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.91%
[DCF Debug] Terminal Value 70.52% ; FCFE base≈929.0m ; Y1≈1.02b ; Y5≈1.30b
Fair Price DCF = 72.33 (DCF Value 14.55b / Shares Outstanding 201.1m; 5y FCF grow 11.03% → 3.0% )
EPS Correlation: 24.48 | EPS CAGR: -41.54% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.00 | Revenue CAGR: 10.78% | SUE: 4.0 | # QB: 5
EPS next Year (2027-01-31): EPS=4.04 | Chg30d=+0.006 | Revisions Net=+1 | Growth EPS=+9.7% | Growth Revenue=+7.0%
P/E Trailing = 51.9265
P/E Forward = 16.8634
P/S = 4.61
P/B = 6.9123
P/EG = 0.4099
Beta = 0.983
Revenue TTM = 3.10b USD
EBIT TTM = 291.9m USD
EBITDA TTM = 476.1m USD
Long Term Debt = 126.9m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 21.2m USD (from shortTermDebt, last quarter)
Debt = 126.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -473.0m USD (from netDebt column, last quarter)
Enterprise Value = 13.55b USD (14.27b + Debt 126.9m - CCE 844.5m)
Interest Coverage Ratio = 134.6 (Ebit TTM 291.9m / Interest Expense TTM 2.17m)
FCF Yield = 6.90% (FCF TTM 935.7m / Enterprise Value 13.55b)
FCF Margin = 30.23% (FCF TTM 935.7m / Revenue TTM 3.10b)
Net Margin = 9.08% (Net Income TTM 281.0m / Revenue TTM 3.10b)
Gross Margin = 79.34% ((Revenue TTM 3.10b - Cost of Revenue TTM 639.5m) / Revenue TTM)
Gross Margin QoQ = 79.33% (prev 79.41%)
Tobins Q-Ratio = 3.43 (Enterprise Value 13.55b / Total Assets 3.95b)
Interest Expense / Debt = 0.65% (Interest Expense 828.0k / Debt 126.9m)
Taxrate = 17.64% (13.5m / 76.5m)
NOPAT = 240.4m (EBIT 291.9m * (1 - 17.64%))
Current Ratio = 0.74 (Total Current Assets 1.32b / Total Current Liabilities 1.78b)
Debt / Equity = 0.06 (Debt 126.9m / totalStockholderEquity, last quarter 1.99b)
Debt / EBITDA = -0.99 (Net Debt -473.0m / EBITDA 476.1m)
Debt / FCF = -0.51 (Net Debt -473.0m / FCF TTM 935.7m)
Total Stockholder Equity = 2.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.11% (Net Income 281.0m / Total Assets 3.95b)
RoE = 14.06% (Net Income TTM 281.0m / Total Stockholder Equity 2.00b)
RoCE = 13.73% (EBIT 291.9m / Capital Employed (Equity 2.00b + L.T.Debt 126.9m))
RoIC = 12.03% (NOPAT 240.4m / Invested Capital 2.00b)
WACC = 10.72% (E(14.27b)/V(14.40b) * Re(10.81%) + D(126.9m)/V(14.40b) * Rd(0.65%) * (1-Tc(0.18)))
Discount Rate = 10.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.91%
[DCF Debug] Terminal Value 70.52% ; FCFE base≈929.0m ; Y1≈1.02b ; Y5≈1.30b
Fair Price DCF = 72.33 (DCF Value 14.55b / Shares Outstanding 201.1m; 5y FCF grow 11.03% → 3.0% )
EPS Correlation: 24.48 | EPS CAGR: -41.54% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.00 | Revenue CAGR: 10.78% | SUE: 4.0 | # QB: 5
EPS next Year (2027-01-31): EPS=4.04 | Chg30d=+0.006 | Revisions Net=+1 | Growth EPS=+9.7% | Growth Revenue=+7.0%
Additional Sources for DOCU Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle